While moderate ROS levels can paradoxically promote cancer cell survival by activating oncogenic pathways and suppressing tumor suppressor genes [97], tumor cells adapt to chronic oxidative stress by upregulating antioxidant systems, particularly through nuclear factor erythroid 2-related factor 2 (Nrf2) mediated transcriptional control [99]. This evidence concerns the gene NFE2L2 and neoplasm.